Clinical Differentiation of Food Transgression, Intestinal Amebiasis, Bacterial Gastroenteritis, and Viral Gastroenteritis

Initial Clinical Differentiation

The American College of Gastroenterology recommends that the initial clinical differentiation be based mainly on the temporal pattern of symptoms, stool characteristics, presence of fever, and epidemiological context, with viral gastroenteritis being the most common (self-limiting in 12-72 hours), followed by bacterial (with fever and bloody diarrhea suggesting invasion), and amebiasis (with a more insidious onset and mucoid bloody diarrhea) 1, 2.

The Infectious Diseases Society of America notes that viral gastroenteritis typically has a sudden onset with an incubation period of 12-48 hours (norovirus) or 1-3 days (rotavirus), prominent vomiting preceding watery diarrhea, low-grade or absent fever, and a self-limiting course of 12-72 hours in immunocompetent individuals 3.

The American College of Gastroenterology states that bacterial gastroenteritis is characterized by high fever (>38.5°C), bloody diarrhea (suggesting Shigella, Salmonella, Campylobacter, or invasive E. coli), severe abdominal pain, and tenesmus, with a duration of more than 3-5 days without improvement 1, 4, 5.

The Centers for Disease Control and Prevention recommend that amebiasis be suspected in patients with a more insidious onset, mucoid bloody diarrhea, and a history of travel to endemic areas, with metronidazol being the treatment of choice 4, 6.

The American Gastroenterological Association suggests that no microbiological studies are required if symptoms are mild and resolve within 7 days, there is no blood in the stool, no high fever, and no immunosuppression, but studies are indicated if there is bloody diarrhea, high fever, or severe symptoms 1, 3, 4.

The World Health Organization recommends oral rehydration with a reduced osmolarity solution as the primary treatment for all cases with mild to moderate dehydration, with intravenous isotonic fluids for severe dehydration, shock, or altered mental status 1, 7.
The Infectious Diseases Society of America notes that antimicrobial therapy is indicated for bacterial gastroenteritis, with ciprofloxacin or azithromycin being the first-line treatment for adults, and ceftriaxone or azithromycin for children 1, 2, 5.
The American College of Gastroenterology recommends that antimotility agents (loperamide) be used with caution, as they are contraindicated in children under 18 years, and in patients with fever, bloody diarrhea, or suspected invasive pathogens 1, 7.

The American College of Gastroenterology states that immunocompromised patients require a lower threshold for empirical antibiotic treatment, and consideration of opportunistic pathogens such as CMV, Cryptosporidium, and Isospora 5, 6.